RecruitingNCT05480150
Gut and brain markers of diagnosis and treatment response in depression and bipolarity
About this title
Read the official source — NCT05480150Medication studyAges 16–65China
Understand this study
Who could participate?
Listed age limits: 16 years to 65 years.
- Listed locations
- HangzhouSee all locations and recruitment
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 1, 2021
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 10,000
- Sponsor
- First Affiliated Hospital of Zhejiang University
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Locations
- China
- Age range
- From 16 Years to 65 Years
- Official registry ID
- NCT05480150
- Official title
Show the full official title
Chinese Longitudinal and Systematic Study of Bioplar Disorder
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Hangzhou
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is First Affiliated Hospital of Zhejiang University, a university.
Does this study involve medication?
Yes. The study involves medication, including Escitalopram Oxalate Tablets, Quetiapine Fumarate Tablets and Lurasidone.
Who can participate?
Listed age limits: 16 years to 65 years.
Is this study still recruiting?
The registry lists this study as recruiting.
